NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 61 filers reported holding NEUBASE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 30 | -94.8% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 576 | -98.8% | 0.00% | – |
| Q2 2022 | $51,000 | -76.3% | 48,497 | -57.6% | 0.00% | – |
| Q1 2022 | $215,000 | +9.7% | 114,473 | +64.3% | 0.00% | – |
| Q4 2021 | $196,000 | +67.5% | 69,682 | +113.8% | 0.00% | – |
| Q3 2021 | $117,000 | -71.6% | 32,585 | -62.1% | 0.00% | – |
| Q2 2021 | $412,000 | +396.4% | 85,955 | +664.5% | 0.00% | – |
| Q1 2021 | $83,000 | +130.6% | 11,244 | +121.1% | 0.00% | – |
| Q4 2020 | $36,000 | +157.1% | 5,086 | +182.6% | 0.00% | – |
| Q3 2020 | $14,000 | -12.5% | 1,800 | 0.0% | 0.00% | – |
| Q2 2020 | $16,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $494,000 | 0.50% |
| CARNEGIE MELLON UNIVERSITY | 939,412 | $986,000 | 0.50% |
| CM Management, LLC | 370,000 | $389,000 | 0.41% |
| Decheng Capital Management III (Cayman), LLC | 1,000,000 | $1,050,000 | 0.40% |
| Sio Capital Management, LLC | 906,445 | $952,000 | 0.36% |
| AIGH Capital Management LLC | 1,027,585 | $1,079,000 | 0.28% |
| Greenlight Capital | 2,727,027 | $2,863,000 | 0.22% |
| Worth Venture Partners, LLC | 256,553 | $249,000 | 0.15% |
| PERKINS CAPITAL MANAGEMENT INC | 81,500 | $86,000 | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $327,000 | 0.01% |